ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;61:1457
© 1996 The Society of Thoracic Surgeons

Discussion

Discussion

The first 20% of the full text of this article appears below.

See also page 1453.

DR HARVEY I. PASS (Bethesda, MD): Thromboxane is one of the early pathways as far as lung injury is concerned. Can you comment on what affect this has on cytokine production and possibly free radicals?

Is there any golden period in which you can rescue animals if you give the blockade either as you start or after you start the . . . [Full Text of this Article]


Related Article

Thromboxane Receptor Blockade Improves Oxygenation in an Experimental Model of Acute Lung Injury
Steven D. Thies, R. Scott Corbin, Charles D. Goff, Oliver A. R. Binns, Scott A. Buchanan, Kimberly S. Shockey, Henry F. Frierson, Jr, Jeffrey S. Young, Curtis G. Tribble, and Irving L. Kron
Ann. Thorac. Surg. 1996 61: 1453-1457. [Abstract] [Full Text]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.